Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2025

Jul 3, 2025

30071_dirs_2025-07-03_aa776968-5fba-45e6-a67d-4c3baff4f1ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-07-02

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-02 ResMed Common Stock S 945 $255.49 Disposed 68273 Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024